Zobrazeno 1 - 10
of 639
pro vyhledávání: '"atrial cardiomyopathy"'
Autor:
Ioan-Alexandru Minciună, Raluca Tomoaia, Dragos Mihăilă, Gabriel Cismaru, Mihai Puiu, Radu Roșu, Gelu Simu, Florina Frîngu, Diana Andrada Irimie, Bogdan Caloian, Dumitru Zdrenghea, Dana Pop
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 9, Pp 9607-9623 (2024)
Atrial cardiomyopathy and remodeling play pivotal roles in the development of atrial fibrillation (AF) and heart failure (HF), involving complex changes in atrial structure and function. These changes facilitate the progression of AF and HF by creati
Externí odkaz:
https://doaj.org/article/76e597fbc47444499e13ae1017817b42
Autor:
Blagovest Stoimenov, Ralitsa Pancheva
Publikováno v:
Journal of IMAB, Vol 30, Iss 2, Pp 5597-5600 (2024)
Atrial cardiomyopathy (ACM) represents a novel paradigm in cardiovascular medicine, encompassing structural and functional changes within the atria that contribute to adverse clinical outcomes, notably stroke. This review explores the multifaceted im
Externí odkaz:
https://doaj.org/article/e45da703bdb44a84b965a3c8642eb785
Autor:
Yazan Mohsen, Dennis Rottländer, Nora Großmann, Nicole Lewandowski, Marc Horlitz, Florian Stöckigt
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundAtrial fibrillation (AF) triggers atrial remodeling, impacting atrial function and ablation efficacy. This remodeling leads to atrial cardiomyopathy and dilatation, linked to mitral regurgitation, forming atrial functional mitral regurgitat
Externí odkaz:
https://doaj.org/article/88d70a7446cc4d8693256725ad956331
Publikováno v:
EBioMedicine, Vol 106, Iss , Pp 105268- (2024)
Summary: Background: Atrial cardiomyopathy (ACM) is responsible for atrial fibrillation (AF) and thromboembolic events. Diabetes mellitus (DM) is an important risk factor for ACM. However, the potential mechanism between ACM and DM remains elusive. M
Externí odkaz:
https://doaj.org/article/433388d763d14d38a344763c52d3f631
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 6, Pp 40-47 (2023)
Latent atrial fibrillation (AF), whose substrate is atrial cardiomyopathy (AC), is considered the main potential pathogenetic mechanism of cryptogenic embolic stroke (CES). Early detection of AC allows to intensify the search for AF in such patients.
Externí odkaz:
https://doaj.org/article/fb53386ddec6493f82e7c55864af9554
Autor:
Yannick Teumer, Luca Gold, Lyuboslav Katov, Carlo Bothner, Wolfgang Rottbauer, Karolina Weinmann-Emhardt
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 10, p 334 (2024)
The incidence of left atrial (LA) supraventricular arrhythmias is increasing. Even after LA ablation, recurrence of these tachycardias is common. MRI studies show that LA cardiomyopathy is a significant risk factor for recurrence and correlates with
Externí odkaz:
https://doaj.org/article/80abd34b5ac14b71a83e0b72e3f56d12
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 10, p 297 (2024)
Advances in cardiovascular imaging have expanded the scope and precision of rare diagnoses. Handling a patient with a giant left atrium, we focused on the existence and associated factors of “lone giant (left or right) atria” in our clinical sett
Externí odkaz:
https://doaj.org/article/ee4556804a714de5a3cd97483fb87a11
Autor:
Adrian M. Petzl, Rajat Deo
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 7 (2024)
Externí odkaz:
https://doaj.org/article/97015d5f01c24ccb82b61565f05b4e38
Autor:
B. A. Tatarsky, D. A. Napalkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 1, Pp 83-88 (2023)
Atrial fibrillation (AF) is strongly associated with stroke risk, but an association by itself does not necessarily imply causation. The question remains whether AF is a risk factor for stroke and whether treatment that reduces the severity of AF wil
Externí odkaz:
https://doaj.org/article/89974a7e9c4945089b52e90f281f1f9a
Autor:
Joris Winters, Aaron Isaacs, Stef Zeemering, Michal Kawczynski, Bart Maesen, Jos Maessen, Elham Bidar, Bas Boukens, Ben Hermans, Arne van Hunnik, Barbara Casadei, Larissa Fabritz, Winnie Chua, Laura Sommerfeld, Eduard Guasch, Luis Mont, Montserrat Batlle, Stephane Hatem, Paulus Kirchhof, Reza Wakili, Mortiz Sinner, Monica Stoll, Andreas Goette, Sander Verheule, Ulrich Schotten
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 22 (2023)
Background Atrial cardiomyopathy (atCM) is an emerging prognostic factor in cardiovascular disease. Fibrotic remodeling, cardiomyocyte hypertrophy, and capillary density are hallmarks of atCM. The contribution of etiological factors and atrial fibril
Externí odkaz:
https://doaj.org/article/6932d4bcd95d49ddb1b11904f1cb0bf7